BioSpace News Archive

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on developing new generation therapies for dermatological and immunological disorders such as atopic dermatitis, psoriasis, asthma and acne, announced today that the Company, after further evaluation under its Commercial Evaluation Sublicense and Option Agreement with the University of Maryland, Baltimore (UMB) and Isoprene Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for viral skin diseases requiring medical interventions, today announced the appointment of two new Vice Presidents in its Commercial Operations group to support the potential launch, if approved, of YCANTH™ (cantharidin 0.7% topical solution),

As you may recall, we believe that the sensor market on the whole is a gamechanger like drones, cannabis, bit-coin, and the like.

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced it has initated a clinical and manufacturing collaboration with Celularity, Inc., a Warren, New Jersey, based clinical-stage cell therapeutics company delivering transformative allogeneic cellular therapies derived from the postpartum human placenta

Early Clinical Data Support ex vivo Hematopoietic Stem Cell Gene Therapy as a Potentially Promising Treatment Option for X-CGD

Decibel Therapeutics, a development-stage biotechnology company developing novel therapeutics for hearing loss and balance disorders, today announced a new strategic research focus on regenerative medicine approaches for the inner ear

Decibel Therapeutics, a development-stage biotechnology company advancing novel therapeutics for hearing loss and balance disorders, today announced that industry veteran Laurence Reid, Ph.D., has been appointed as Decibel’s acting chief executive officer, bringing deep experience in biotech company building.

Elixicure’s Over-The-Counter Drug Registration has been Certified by the U.S. Food and Drug Administration (FDA) for its Elixicure CBD-Infused Pain Relief products following a successful year-long process, announced Elixicure Chief of Business Development Yaniv Kotler

Cohen Veterans Bioscience (CVB), a leading non-profit research biotech dedicated to fast-tracking brain science, new diagnostic research and therapeutic solutions, announces that traumatic brain injuries (TBIs) -- the grossly understudied “invisible wounds” afflicting today’s soldiers – are under-detected and under-treated.

A surgical team at The Chaim Sheba Medical Center in Tel HaShomer, Israel, with coordination by US Medical Innovations, LLC (USMI), successfully used the Canady HeliosTM Cold Plasma Scalpel (CHCPS) for a rare advanced reoccurring inoperable retroperitoneal sarcoma.